What Is Suboxone?

If you or someone you love is exploring treatment for opioid addiction, you've probably come across the name Suboxone. It's one of the most widely used medications for opioid use disorder (OUD), and it works by targeting the same brain receptors that opioids act on—without producing the same intense high.

Here's a plain-English breakdown of what Suboxone actually is, what it's approved for, and how it fits into a real recovery plan.

What Suboxone Contains

Suboxone combines two medications in one sublingual film: buprenorphine and naloxone.

Buprenorphine is a partial opioid agonist. That means it activates opioid receptors in the brain enough to ease cravings and withdrawal symptoms, but only partially—so it doesn't produce the same intense euphoria full opioids like heroin, fentanyl, or oxycodone do. According to the National Institute on Drug Abuse (NIDA), buprenorphine can reduce cravings and withdrawal symptoms without producing intense feelings of pleasure and intoxication.

Naloxone is an opioid antagonist, meaning it blocks opioid receptors rather than activating them. In Suboxone, naloxone is included specifically to discourage misuse. When taken as directed (dissolved under the tongue), naloxone has minimal effect. But if someone tried to dissolve and inject the medication, the naloxone would trigger withdrawal symptoms, making that route far less appealing. The SAMHSA Buprenorphine Quick Start Guide notes that naloxone-containing formulations are added "to prevent injection diversion," and this combination product is generally considered the preferred treatment medication, with buprenorphine-only products reserved mainly for specific situations, such as pregnancy, to limit the baby's exposure to naloxone.

What Suboxone Treats

Suboxone is FDA-approved for the treatment of opioid dependence, also referred to clinically as opioid use disorder. This includes dependence on prescription opioids (like oxycodone or hydrocodone) as well as illicit opioids such as heroin or fentanyl.

Opioid use disorder affects a significant number of people in the United States. The FDA notes that over 6.1 million people aged 12 and older in the U.S. have opioid use disorder. Medications like Suboxone are considered a frontline, evidence-based treatment option—not a last resort.

How Suboxone Is Taken

Suboxone comes as a thin film that you place under your tongue (sublingual) or against the inside of your cheek (buccal), where it dissolves. It is not swallowed like a pill—swallowing it whole significantly reduces how well the medication is absorbed. Your provider will give you specific instructions on dosing, since the right dose depends on factors like which opioids you've been using, how long you've been using them, and how your body responds during your induction (the initial period when you first start the medication).

Why It's Part of a Bigger Treatment Plan

Suboxone isn't designed to be used in isolation. Per its FDA labeling, it's intended to be one part of a complete treatment approach that also includes counseling and psychosocial support. The medication helps stabilize brain chemistry and reduce cravings and withdrawal, which creates the physical and mental space needed to engage in the other work of recovery—therapy, support groups, lifestyle changes, and addressing whatever led to opioid use in the first place.

This is also why buprenorphine treatment today looks different than it did a decade ago. As of a 2023 policy change, the federal "X-Waiver" requirement that once limited which providers could prescribe buprenorphine has been eliminated, making it easier for patients to access this treatment through more providers, including via telehealth.

How Suboxone Compares to Other Buprenorphine Options

Suboxone is a brand-name buprenorphine/naloxone film, but it's not the only option. Generic buprenorphine/naloxone films and tablets work the same way and are often more accessible. There are also extended-release buprenorphine injections, such as Sublocade and Brixadi, which are administered monthly or biweekly by a provider instead of being taken daily at home. NIDA notes that several buprenorphine products are approved, including sublingual tablets, extended-release injections, and implants, with some combining buprenorphine with naloxone. We cover how these options differ in more detail in our article on buprenorphine treatment options, but the short version is: the active medication doing the therapeutic work is similar, while the form, dosing schedule, and diversion-prevention approach vary.

This article is for general educational purposes and isn't a substitute for individualized medical advice. Your treatment plan should be developed with your own provider based on your specific health history.